Expression of p16INK4a prevents cancer and promotes aging in lymphocytes

Blood

Volumn 117, Issue 12, 2011, Pages 3257-3267

  Liu, Yan ^a   Johnson, Soren M ^a   Fedoriw, Yuri ^a   Rogers, Arlin B ^a   Yuan, Hong ^a   Krishnamurthy, Janakiraman ^a   Sharpless, Norman E ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; CYCLIN DEPENDENT KINASE INHIBITOR 2A;

AGING; ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; B CELL NEOPLASM; B LYMPHOCYTE; CANCER INHIBITION; CANCER PREVENTION; CARCINOGENESIS; CELL MATURATION; CONTROLLED STUDY; GENE DELETION; IMMUNE FUNCTION TEST; IMMUNE RESPONSE; INVOLUTION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MOUSE; NEOPLASM; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T CELL NEOPLASIA; T LYMPHOCYTE; THYMOCYTE;

EID: 79953086335     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-09-304402     Document Type: Article

References (50)

1. Williams GC. Pleiotropy, natural selection, and the evolution of senescence. Evolution. 1957;11: 398-411.
2. Campisi J. Cancer and ageing: rival demons? Nat Rev Cancer. 2003;3(5):339-349.
3. Collado M, Blasco MA, Serrano M. Cellular senescence in cancer and aging. Cell. 2007;130(2): 223-233. (Pubitemid 47081143)
4. Sharpless NE, DePinho RA. How stem cells age and why this makes us grow old. Nat Rev. 2007; 8(9):703-713. (Pubitemid 47312828)
5. Janzen V, Forkert R, Fleming HE, et al. Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a. Nature. 2006;443(7110):421-426. (Pubitemid 44477274)
6. Krishnamurthy J, Ramsey MR, Ligon KL, et al. p16INK4a induces an age-dependent decline in islet regenerative potential. Nature. 2006;443(7110): 453-457. (Pubitemid 44477281)
7. Chen H, Gu X, Su IH, et al. Polycomb protein Ezh2 regulates pancreatic beta-cell Ink4a/Arf expression and regeneration in diabetes mellitus. Genes Dev. 2009;23(8):975-985.
8. Molofsky AV, Slutsky SG, Joseph NM, et al. Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing. Nature. 2006;443(7110):448-452. (Pubitemid 44477280)
9. Baker DJ, Perez-Terzic C, Jin F, et al. Opposing roles for p16Ink4a and p19Arf in senescence and ageing caused by BubR1 insufficiency. Nat Cell Biol. 2008;10(7):825-836.
10. Emanuele E, Fontana JM, Minoretti P, Geroldi D. Preliminary evidence of a genetic association between chromosome 9p21.3 and human longevity. Rejuvenation Res. 2010;13(1):23-26.
11. Turnbull C, Ahmed S, Morrison J, et al. Genomewide association study identifies five new breast cancer susceptibility loci. Nat Genet. 2010;42(6): 504-507.
12. Bishop DT, Demenais F, Iles MM, et al. Genomewide association study identifies three loci associated with melanoma risk. Nat Genet. 2009;41(8): 920-925.
13. Wrensch M, Jenkins RB, Chang JS, et al. Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet. 2009;41(8):905-908.
14. Sherborne AL, Hosking FJ, Prasad RB, et al. Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk. Nat Genet. 2010;42(6):492-494.
15. Liu Y, Sanoff HK, Cho H, et al. INK4/ARF transcript expression is associated with chromosome 9p21 variants linked to atherosclerosis. PLoS One. 2009;4(4):e5027.
16. Cunnington MS, Santibanez Koref M, Mayosi BM, Burn J, Keavney B. Chromosome 9p21 SNPs associated with multiple disease phenotypes correlate with ANRIL expression. PLoS Genet. 2010; 6(4):e1000899.
17. Liu Y, Sanoff HK, Cho H, et al. Expression of p16(INK4a) in peripheral blood T-cells is a biomarker of human aging. Aging Cell. 2009;8(4): 439-448.
18. Lagresle C, Gardie B, Eyquem S, et al. Transgenic expression of the p16(INK4a) cyclindependent kinase inhibitor leads to enhanced apoptosis and differentiation arrest of CD4-CD8- immature thymocytes. J Immunol. 2002;168(5): 2325-2331. (Pubitemid 34171834)
19. Erickson S, Sangfelt O, Heyman M, Castro J, Einhorn S, Grander D. Involvement of the Ink4 proteins p16 and p15 in T-lymphocyte senescence. Oncogene. 1998;17(5):595-602. (Pubitemid 28401028)
20. Migliaccio M, Raj K, Menzel O, Rufer N. Mechanisms that limit the in vitro proliferative potential of human CD8+ T lymphocytes. J Immunol. 2005; 174(6):3335-3343. (Pubitemid 40354037)
21. Sharpless NE, Bardeesy N, Lee KH, et al. Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis. Nature. 2001;413(6851): 86-91. (Pubitemid 32843493)
22. Bianchi T, Rufer N, MacDonald HR, Migliaccio M. The tumor suppressor p16(Ink4a) regulates T lymphocyte survival. Oncogene. 2006;25(29): 4110-4115. (Pubitemid 44024873)
23. Lemster BH, Michel JJ, Montag DT, et al. Induction of CD56 and TCR-independent activation of T cells with aging. J Immunol. 2008;180(3):1979-1990.
24. Sulong S, Moorman AV, Irving JA, et al. A comprehensive analysis of the CDKN2A gene in childhood acute lymphoblastic leukemia reveals genomic deletion, copy number neutral loss of heterozygosity, and association with specific cytogenetic subgroups. Blood. 2009;113(1):100-107.
25. Williams RT, Roussel MF, Sherr CJ. Arf gene loss enhances oncogenicity and limits imatinib response in mouse models of Bcr-Abl-induced acute lymphoblastic leukemia. Proc Natl Acad Sci U S A. 2006;103(17):6688-6693.
26. Kohno T, Yamada Y, Tawara M, et al. Inactivation of p14ARF as a key event for the progression of adult T cell leukemia/lymphoma. Leukemia Res. 2007;31(12):1625-1632.
27. Bies J, Sramko M, Fares J, et al. Myeloid specific inactivation of p15Ink4b results in monocytosis and predisposition to myeloid leukemia. Blood. 2010;116(6):979-987
28. Wolff L, Garin MT, Koller R, et al. Hypermethylation of the Ink4b locus in murine myeloid leukemia and increased susceptibility to leukemia in p15(Ink4b)-deficient mice. Oncogene. 2003; 22(58):9265-9274. (Pubitemid 38122038)
29. Signer RA, Montecino-Rodriguez E, Witte ON, Dorshkind K. Aging and cancer resistance in lymphoid progenitors are linked processes conferred by p16Ink4a and Arf. Genes Dev. 2008;22(22): 3115-3120.
30. Monahan KB, Rozenberg GI, Krishnamurthy J, et al. Somatic p16INK4a loss accelerates melanomagenesis. Oncogene. 2010;29(43):5809-5817.
31. Takahama Y, Ohishi K, Tokoro Y, et al. Functional competence of T cells in the absence of glycosylphosphatidylinositol-anchored proteins caused by T cell-specific disruption of the Pig-a gene. Eur J Immunol. 1998;28(7):2159-2166. (Pubitemid 28321300)
32. Rickert RC, Roes J, Rajewsky K. B lymphocyte-specific, Cre-mediated mutagenesis in mice. Nucleic Acids Res. 1997;25(6):1317-1318.
33. Ramsey MR, Krishnamurthy J, Pei XH, et al. Expression of p16Ink4a compensates for p18Ink4c loss in cyclin-dependent kinase 4/6-dependent tumors and tissues. Cancer Res. 2007;67(10): 4732-4741. (Pubitemid 46910180)
34. Krimpenfort P, Ijpenberg A, Song JY, et al. p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a. Nature. 2007;448(7156): 943-946. (Pubitemid 47312779)
35. Thoman ML. The pattern of T lymphocyte differentiation is altered during thymic involution. Mech Ageing Dev. 1995;82(2-3):155-170.
36. Aspinall R. Age-associated thymic atrophy in the mouse is due to a deficiency affecting rearrangement of the TCR during intrathymic T cell development. J Immunol. 1997;158(7):3037-3045. (Pubitemid 127484015)
37. Thoman ML. Early steps in T cell development are affected by aging. Cell Immunol. 1997;178(2): 117-123. (Pubitemid 27397594)
38. Pirruccello SJ, Collins M, Wilson JE, Mcmanus BM. Age-related changes in naive and memory Cd4+ T-cells in healthy-human children. Clin Immunol Immunopathol. 1989;52(2):341-345. (Pubitemid 19177757)
39. De Paoli P, Battistin S, Santini GF. Age-related changes in human-lymphocyte subsets-progressive reduction of the Cd4 Cd45r (suppressor inducer) population. Clin Immunol Immunopathol. 1988;48(3):290-296.
40. Ernst DN, Hobbs MV, Torbett BE, et al. Differences in the expression profiles of Cd45rb, Pgp-1, and 3g11 membrane-antigens and in the patterns of lymphokine secretion by splenic-Cd4+ T-cells from young and aged mice. J Immunol. 1990;145(5):1295-1302. (Pubitemid 20255029)
41. Cho BK,Wang CY, Sugawa S, Eisen HN, Chen JZ. Functional differences between memory and naive CD8 T cells. Proc Natl Acad Sci U S A. 1999;96(6):2976-2981. (Pubitemid 29148829)
42. Cicin-Sain L, Messaoudi I, Park B, et al. Dramatic increase in naive T cell turnover is linked to loss of naive T cells from old primates. Proc Natl Acad Sci U S A. 2007;104(50):19960-19965.
43. Ahmed M, Lanzer KG, Yager EJ, Adams PS, Johnson LL, Blackman MA. Clonal expansions and loss of receptor diversity in the naive CD8 T cell repertoire of aged mice. J Immunol. 2009; 182(2):784-792.
44. Naylor K, Li GJ, Vallejo AN, et al. The influence of age on T cell generation and TCR diversity. J Immunol. 2005;174(11):7446-7452. (Pubitemid 40705717)
45. Carlson ME, Hsu M, Conboy IM. Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells. Nature. 2008;454(7203): 528-532.
46. Aspinall R, Andrew D. Thymic atrophy in the mouse is a soluble problem of the thymic environment. Vaccine. 2000;18(16):1629-1637. (Pubitemid 30109520)
47. Mackall CL, Punt JA, Morgan P, Farr AG, Gress RE. Thymic function in young/old chimeras: substantial thymic T cell regenerative capacity despite irreversible age-associated thymic involution. Eur J Immunol. 1998;28(6):1886-1893. (Pubitemid 28271705)
48. Min H, Montecino-Rodriguez E, Dorshkind K. Reduction in the developmental potential of intrathymic T cell progenitors with age. J Immunol. 2004;173(1):245-250. (Pubitemid 38797348)
49. Bai F, Pei XH, Pandolfi PP, Xiong Y. p18(Ink4c) and Pten constrain a positive regulatory loop between cell growth and cell cycle control. Mol Cell Biol. 2006;26(12):4564-4576. (Pubitemid 43877575)
50. Inomata K, Aoto T, Binh NT, et al. Genotoxic stress abrogates renewal of melanocyte stem cells by triggering their differentiation. Cell. 2009; 137(6):1088-1099.